Immune responses to COVID-19 vaccination in people living with HIV

This webinar will be presented by:

Zabrina Brumme, Ph.D.
Laboratory Director, BC Centre for Excellence in HIV/AIDS
Professor, Faculty of Health Sciences
Simon Fraser University
Scholar, Michael Smith Foundation for Health Research

Following this webinar, participants will be able to:

  • Describe broadly studies to date that have measured immune responses to COVID-19 vaccination in people living with HIV
  • Summarize the results from a Vancouver-based study that is comparing antibody responses to COVID-19 vaccination among people living with HIV who are receiving suppressive antiretroviral therapy, compared to a control group of individuals without HIV
  • Recognize factors that influence the antibody response to COVID-19 vaccines, which include age, a higher number of chronic conditions, and the type of initial vaccine regimen received.

Presentations will be followed by a discussion where participants will have the opportunity to ask questions and receive real-time responses from presenters.


Cost: Free registration.

Please register for the webinar by clicking the following link:

click here.

If you are unable to attend the live webinar it will be recorded and available for viewing on BC-CfE’s Education and Training website at: education.bccfe.ca/webinars

This event is accredited by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1 Mainpro+ credit.

If you have any questions regarding this event, please contact BC-CfE’s Education and Training team at: education@bccfe.ca.


Event Details

Days
Hours
Minutes
Seconds
Start Date
End Date
Event Category
Attendees of the BC-CfE Learning Series will be able to:
  • Summarize and describe epidemiological, behavioural, virological, and other related research relevant to the management of people living with HIV and other syndemic conditions
  • Describe and demonstrate up-to-date information regarding the care of people living with HIV and syndemic conditions (including viral hepatitis and substance use) particularly in regards to primary care, antiretroviral therapy and other treatments, and comorbid conditions
  • Review new and emerging issues in the context of the management of people living with HIV and other syndemic conditions
  • Identify both clinical and community resources to support the care of people living with HIV and syndemic conditions.
Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below